Generation of ‘designer erythroblasts’ lacking one or more blood group systems from CRISPR/Cas9 gene‐edited human‐induced pluripotent stem cells
Open Access
- 21 September 2021
- journal article
- research article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 25 (19) , 9340-9349
Abstract
Despite the recent advancements in transfusion medicine, red blood cell (RBC) alloimmunization remains a challenge for multiparous women and chronically transfused patients. At times, diagnostic laboratories depend on difficult‐to‐procure rare reagent RBCs for the identification of different alloantibodies in such subjects. We have addressed this issue by developing erythroblasts with custom phenotypes (Rh null, GPB null and Kx null/Kell low) using CRISPR/Cas9 gene‐editing of a human induced pluripotent stem cell (hiPSC) parent line (OT1‐1) for the blood group system genes: RHAG, GYPB and XK. Guide RNAs were cloned into Cas9‐puromycin expression vector and transfected into OT1‐1. Genotyping was performed to select puromycin‐resistant hiPSC KOs. CRISPR/Cas9 gene‐editing resulted in the successful generation of three KO lines, RHAG KO, GYPB KO and XK KO. The OT1‐1 cell line, as well as the three KO hiPSC lines, were differentiated into CD34+CD41+CD235ab+ hematopoietic progenitor cells (HPCs) and subsequently to erythroblasts. Native OT1‐1 erythroblasts were positive for the expression of Rh, MNS, Kell and H blood group systems. Differentiation of RHAG KO, GYPB KO and XK KO resulted in the formation of Rh null, GPB null and Kx null/Kell low erythroblasts, respectively. OT1‐1 as well as the three KO erythroblasts remained positive for RBC markers—CD71 and BAND3. Erythroblasts were mostly at the polychromatic/ orthochromatic stage of differentiation. Up to ~400‐fold increase in erythroblasts derived from HPCs was observed. The availability of custom erythroblasts generated from CRISPR/Cas9 gene‐edited hiPSC should be a useful addition to the tools currently used for the detection of clinically important red cell alloantibodies.Keywords
This publication has 63 references indexed in Scilit:
- Erythropoietin critically regulates the terminal maturation of murine and human primitive erythroblastsHaematologica, 2013
- Establishment of Immortalized Human Erythroid Progenitor Cell Lines Able to Produce Enucleated Red Blood CellsPLOS ONE, 2013
- From stem cell to red cell: regulation of erythropoiesis at multiple levels by multiple proteins, RNAs, and chromatin modificationsBlood, 2011
- Generation of Red Blood Cells from Human Induced Pluripotent Stem CellsStem Cells and Development, 2011
- Molecular genetics and clinical applications for RHTransfusion and Apheresis Science, 2011
- The Notch2–Jagged1 interaction mediates stem cell factor signaling in erythropoiesisCell Death & Differentiation, 2010
- Blood group genotyping by high-throughput DNA analysis: Application to the French panel of RBC reagentsTransfusion Clinique et Biologique, 2010
- Red blood cell generation from human induced pluripotent stem cells: perspectives for transfusion medicineHaematologica, 2010
- The Structure and Function of the Rh Antigen ComplexSeminars in Hematology, 2007
- Delayed Overt Hemolytic Transfusion Reaction Due to Anti‐U AntibodyTransfusion, 1976